05/19/2026
Repurposed drug research is gaining attention because scientists often study whether existing medications can have new uses beyond their original purpose.
This approach can be appealing because older drugs may already have known safety profiles, lower costs, and wider availability compared with brand-new treatments.
Interest in combinations like ivermectin and mebendazole has grown as people look for alternative pathways in complex diseases where standard treatment can be difficult or expensive.
Drug repurposing also reflects a larger shift in medicine, where researchers explore how different compounds may affect inflammation, cell behavior, immune activity, or disease progression.
The bigger conversation is about whether existing medicines could play future supportive roles in treatment strategies when studied carefully and used under professional guidance.
